Acoramidis (AG10)
AG10-504
Phase 3 small_molecule active
Quick answer
Acoramidis (AG10) for Amyloidosis in Transthyretin (TTR) is a Phase 3 program (small_molecule) at BridgeBio Oncology Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BridgeBio Oncology Therapeutics
- Indication
- Amyloidosis in Transthyretin (TTR)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active